265 related articles for article (PubMed ID: 22184106)
1. Prolyl isomerase Pin1 promotes amyloid precursor protein (APP) turnover by inhibiting glycogen synthase kinase-3β (GSK3β) activity: novel mechanism for Pin1 to protect against Alzheimer disease.
Ma SL; Pastorino L; Zhou XZ; Lu KP
J Biol Chem; 2012 Mar; 287(10):6969-73. PubMed ID: 22184106
[TBL] [Abstract][Full Text] [Related]
2. The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-beta production.
Pastorino L; Sun A; Lu PJ; Zhou XZ; Balastik M; Finn G; Wulf G; Lim J; Li SH; Li X; Xia W; Nicholson LK; Lu KP
Nature; 2006 Mar; 440(7083):528-34. PubMed ID: 16554819
[TBL] [Abstract][Full Text] [Related]
3. Tau and GSK3beta dephosphorylations are required for regulating Pin1 phosphorylation.
Min SH; Cho JS; Oh JH; Shim SB; Hwang DY; Lee SH; Jee SW; Lim HJ; Kim MY; Sheen YY; Lee SH; Kim YK
Neurochem Res; 2005 Aug; 30(8):955-61. PubMed ID: 16258844
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of glycogen synthase kinase-3 reverses tau hyperphosphorylation induced by Pin1 down-regulation.
Xiong YS; Wang DL; Tan L; Wang X; Chen LM; Gong CX; Wang JZ; Zhu LQ
CNS Neurol Disord Drug Targets; 2013 May; 12(3):436-43. PubMed ID: 23469846
[TBL] [Abstract][Full Text] [Related]
5. Isomerase Pin1 stimulates dephosphorylation of tau protein at cyclin-dependent kinase (Cdk5)-dependent Alzheimer phosphorylation sites.
Kimura T; Tsutsumi K; Taoka M; Saito T; Masuda-Suzukake M; Ishiguro K; Plattner F; Uchida T; Isobe T; Hasegawa M; Hisanaga SI
J Biol Chem; 2013 Mar; 288(11):7968-7977. PubMed ID: 23362255
[TBL] [Abstract][Full Text] [Related]
6. Melatonin ameliorates Aβ
Chinchalongporn V; Shukla M; Govitrapong P
J Pineal Res; 2018 May; 64(4):e12470. PubMed ID: 29352484
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effects of regulators of the glycogen synthase kinase-3beta signaling pathway in a transgenic model of Alzheimer's disease are associated with reduced amyloid precursor protein phosphorylation.
Rockenstein E; Torrance M; Adame A; Mante M; Bar-on P; Rose JB; Crews L; Masliah E
J Neurosci; 2007 Feb; 27(8):1981-91. PubMed ID: 17314294
[TBL] [Abstract][Full Text] [Related]
8. Interplay between cyclin-dependent kinase 5 and glycogen synthase kinase 3 beta mediated by neuregulin signaling leads to differential effects on tau phosphorylation and amyloid precursor protein processing.
Wen Y; Planel E; Herman M; Figueroa HY; Wang L; Liu L; Lau LF; Yu WH; Duff KE
J Neurosci; 2008 Mar; 28(10):2624-32. PubMed ID: 18322105
[TBL] [Abstract][Full Text] [Related]
9. Hyperphosphorylation of Tau induced by naturally secreted amyloid-β at nanomolar concentrations is modulated by insulin-dependent Akt-GSK3β signaling pathway.
Tokutake T; Kasuga K; Yajima R; Sekine Y; Tezuka T; Nishizawa M; Ikeuchi T
J Biol Chem; 2012 Oct; 287(42):35222-35233. PubMed ID: 22910909
[TBL] [Abstract][Full Text] [Related]
10. Cancer and Alzheimer's disease inverse relationship: an age-associated diverging derailment of shared pathways.
Lanni C; Masi M; Racchi M; Govoni S
Mol Psychiatry; 2021 Jan; 26(1):280-295. PubMed ID: 32382138
[TBL] [Abstract][Full Text] [Related]
11. Prolyl-peptidyl isomerase, Pin1, phosphorylation is compromised in association with the expression of the HFE polymorphic allele, H63D.
Hall EC; Lee SY; Simmons Z; Neely EB; Nandar W; Connor JR
Biochim Biophys Acta; 2010 Apr; 1802(4):389-95. PubMed ID: 20060900
[TBL] [Abstract][Full Text] [Related]
12. GSK3β is involved in promoting Alzheimer's disease pathologies following chronic systemic exposure to Porphyromonas gingivalis lipopolysaccharide in amyloid precursor protein
Jiang M; Zhang X; Yan X; Mizutani S; Kashiwazaki H; Ni J; Wu Z
Brain Behav Immun; 2021 Nov; 98():1-12. PubMed ID: 34391814
[TBL] [Abstract][Full Text] [Related]
13. Pin1 in Alzheimer's disease.
Butterfield DA; Abdul HM; Opii W; Newman SF; Joshi G; Ansari MA; Sultana R
J Neurochem; 2006 Sep; 98(6):1697-706. PubMed ID: 16945100
[TBL] [Abstract][Full Text] [Related]
14. Neuropathogenic role of adenylate kinase-1 in Aβ-mediated tau phosphorylation via AMPK and GSK3β.
Park H; Kam TI; Kim Y; Choi H; Gwon Y; Kim C; Koh JY; Jung YK
Hum Mol Genet; 2012 Jun; 21(12):2725-37. PubMed ID: 22419736
[TBL] [Abstract][Full Text] [Related]
15. A PIN1 polymorphism that prevents its suppression by AP4 associates with delayed onset of Alzheimer's disease.
Ma SL; Tang NL; Tam CW; Lui VW; Lam LC; Chiu HF; Driver JA; Pastorino L; Lu KP
Neurobiol Aging; 2012 Apr; 33(4):804-13. PubMed ID: 20580132
[TBL] [Abstract][Full Text] [Related]
16. Oxidative modification and down-regulation of Pin1 in Alzheimer's disease hippocampus: A redox proteomics analysis.
Sultana R; Boyd-Kimball D; Poon HF; Cai J; Pierce WM; Klein JB; Markesbery WR; Zhou XZ; Lu KP; Butterfield DA
Neurobiol Aging; 2006 Jul; 27(7):918-25. PubMed ID: 15950321
[TBL] [Abstract][Full Text] [Related]
17. Pin1 flips Alzheimer's switch.
Etzkorn FA
ACS Chem Biol; 2006 May; 1(4):214-6. PubMed ID: 17163675
[TBL] [Abstract][Full Text] [Related]
18. Association studies between common variants in prolyl isomerase Pin1 and the risk for late-onset Alzheimer's disease.
Nowotny P; Bertelsen S; Hinrichs AL; Kauwe JS; Mayo K; Jacquart S; Morris JC; Goate A
Neurosci Lett; 2007 May; 419(1):15-7. PubMed ID: 17482359
[TBL] [Abstract][Full Text] [Related]
19. DNA sequence variations in the prolyl isomerase Pin1 gene and Alzheimer's disease.
Poli M; Gatta LB; Dominici R; Lovati C; Mariani C; Albertini A; Finazzi D
Neurosci Lett; 2005 Dec; 389(2):66-70. PubMed ID: 16095818
[TBL] [Abstract][Full Text] [Related]
20. Glycogen synthase kinase-3β (GSK3β) expression in a mouse model of Alzheimer's disease: a light and electron microscopy study.
Gandy JC; Melendez-Ferro M; Bijur GN; Van Leuven F; Roche JK; Lechat B; Devijver H; Demedts D; Perez-Costas E; Roberts RC
Synapse; 2013 Jun; 67(6):313-27. PubMed ID: 23390016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
